ES2147780T3 - Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos. - Google Patents
Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.Info
- Publication number
- ES2147780T3 ES2147780T3 ES94900557T ES94900557T ES2147780T3 ES 2147780 T3 ES2147780 T3 ES 2147780T3 ES 94900557 T ES94900557 T ES 94900557T ES 94900557 T ES94900557 T ES 94900557T ES 2147780 T3 ES2147780 T3 ES 2147780T3
- Authority
- ES
- Spain
- Prior art keywords
- oak bark
- bark extract
- ions
- procedure
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 241000219492 Quercus Species 0.000 abstract 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000000453 Skin Neoplasms Diseases 0.000 abstract 1
- 206010040943 Skin Ulcer Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 229910001424 calcium ion Inorganic materials 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910001414 potassium ion Inorganic materials 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229910001419 rubidium ion Inorganic materials 0.000 abstract 1
- 231100000019 skin ulcer Toxicity 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Road Paving Structures (AREA)
- Laminated Bodies (AREA)
Abstract
LAS CONCENTRACIONES MAS ALTAS DE EXTRACTO DE CENIZA DE CORTEZA DE ROBLE, POR EJEMPLO, MAS GRANDES QUE EL 20% DE PESO, SON UTILES PARA EL TRATAMIENTO DE CANCERES DE PIEL. LAS CONCENTRACIONES DE EXTRACTO DE CORTEZA DE ROBLE POSEEN PROPIEDADES TERAPEUTICAS ADICIONALES NO POR ELLO RECONOCIDAS. POR EJEMPLO, LOS PREPARADOS QUE CONTIENEN EL 40-80% DE EXTRACTOS DE CORTEZA DE ROBLE SON UTILES EN EL TRATAMIENTO DE ULCERAS DE PIEL CANCEROSAS AGUDAS. EN ADICION, LAS MEZCLAS SINTETICAS QUE CONTIENEN IONES DE POTASIO, IONES DE ZINC, IONES DE CALCIO PROVEEN MUCHAS DE LAS MISMAS PROPIEDADES VENTAJOSAS DEL EXTRACTO DE CORTEZA DE ROBLE. LA INCLUSION DE IONES DE RUBIDIO Y AZUFRE ES TAMBIEN VENTAJOSA PARA ALGUNAS APLICACIONES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97307192A | 1992-11-06 | 1992-11-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2147780T3 true ES2147780T3 (es) | 2000-10-01 |
Family
ID=25520460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94900557T Expired - Lifetime ES2147780T3 (es) | 1992-11-06 | 1993-11-04 | Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6149947A (es) |
| EP (1) | EP0668769B1 (es) |
| JP (1) | JP3640215B2 (es) |
| AT (1) | ATE191850T1 (es) |
| AU (1) | AU700019B2 (es) |
| BR (1) | BR9307401A (es) |
| CA (1) | CA2148795C (es) |
| CY (1) | CY2231B1 (es) |
| CZ (1) | CZ117395A3 (es) |
| DE (1) | DE69328438T2 (es) |
| DK (1) | DK0668769T3 (es) |
| ES (1) | ES2147780T3 (es) |
| HU (1) | HUT73791A (es) |
| MX (1) | MX9306960A (es) |
| NO (1) | NO951740L (es) |
| NZ (1) | NZ258019A (es) |
| OA (1) | OA10153A (es) |
| PL (1) | PL308770A1 (es) |
| PT (1) | PT668769E (es) |
| WO (1) | WO1994011010A2 (es) |
| ZA (1) | ZA938274B (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7014870B1 (en) * | 1992-11-06 | 2006-03-21 | Greystone Medical Group, Inc. | Compositions of oak bark extract related synthetic compositions and method of using same |
| AUPN104895A0 (en) * | 1995-02-10 | 1995-03-09 | Lai, John | Methods of and preparations for the treatment of ailments and disorders |
| US20040037898A1 (en) * | 1997-10-08 | 2004-02-26 | Hon David N.S | Compositions of oak bark extract, related synthetic compositions and method of using same |
| RU2125460C1 (ru) * | 1997-11-17 | 1999-01-27 | Закрытое акционерное общество научно-производственная фирма "Новь" | Биостимулирующее средство |
| US20050033251A1 (en) * | 1998-12-08 | 2005-02-10 | Quick-Med Technologies, Inc. | Controlled release of biologically active substances from select substrates |
| NZ533252A (en) * | 2001-11-29 | 2006-03-31 | Greystone Medical Group Inc | Treatment of wounds and compositions employed |
| US20040170703A1 (en) * | 2001-11-29 | 2004-09-02 | Greystone Medical Group, Inc. | Reduction of reactive oxygen species in chronic wound management |
| US6667026B1 (en) | 2002-03-15 | 2003-12-23 | Pocono Falls, Inc. | Allergic contact dermatitis treatment and composition therefor |
| EP1507542A4 (en) * | 2002-05-24 | 2008-01-23 | Greystone Medical Group Inc | ANTICANCER PREPARATION |
| WO2004057965A1 (en) * | 2002-12-23 | 2004-07-15 | Greystone Medical Group, Inc. | Reduction of reactive oxygen species in chronic wound management |
| WO2005000328A1 (en) * | 2003-06-24 | 2005-01-06 | Zanti Gianfranco | Compositions based on plant ash for the treatment of skin diseases |
| EP1906941A4 (en) * | 2004-06-22 | 2011-08-10 | Greystone Medical Group Inc | METHOD FOR TREATING WOUNDS COMPRISING DELAYED RELEASE COMPOSITIONS |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| JP5038331B2 (ja) | 2006-02-03 | 2012-10-03 | ジェイアール ケム エルエルシー | 銅と亜鉛の組成物を用いた老化防止治療 |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| WO2008111090A1 (en) * | 2007-03-15 | 2008-09-18 | Om Kataria | Uterine stimulant sticks |
| ES2652114T3 (es) | 2007-10-15 | 2018-01-31 | 7 Oaks Pharmaceutical Corporation | Una disolución que contiene silicato para uso en el tratamiento de melanoma |
| US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| WO2010085753A1 (en) | 2009-01-23 | 2010-07-29 | Jr Chem, Llc | Rosacea treatments and kits for performing them |
| US20110200655A1 (en) * | 2010-02-16 | 2011-08-18 | Michael Darryl Black | Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
| US8828449B2 (en) | 2012-01-26 | 2014-09-09 | Libby Robinson | Wound dressing composition and method of use |
| US9351995B1 (en) | 2011-04-29 | 2016-05-31 | Red Oax Holdings, LLC | Compositions and methods of enhancing wound healing |
| WO2013012968A1 (en) | 2011-07-20 | 2013-01-24 | 3M Innovative Properties Company | Dressing with ion-carrying composition |
| WO2013016255A1 (en) * | 2011-07-28 | 2013-01-31 | 3M Innovative Properties Company | Wound-healing compositions and method of use |
| JP6697842B2 (ja) | 2011-08-17 | 2020-05-27 | スリーエム イノベイティブ プロパティズ カンパニー | モノマーグラフト化繊維及びその使用 |
| GB201402672D0 (en) | 2014-02-14 | 2014-04-02 | Medical Res Council | Materials and methods relating to stabilised polymeric silicate compositions |
| WO2016123539A1 (en) | 2015-01-29 | 2016-08-04 | Wardell Mark R | Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use |
| AU2019433065B2 (en) * | 2019-03-04 | 2022-08-18 | Aurealis Therapeutics AG | Chloride-inducible prokaryotic expression system |
| IT201900018047A1 (it) * | 2019-10-07 | 2021-04-07 | Nello Vallicella | Procedimento per la preparazione di una composizione topica liquida. |
| WO2024196897A1 (en) * | 2023-03-22 | 2024-09-26 | Courtland Imel | Novel methods for increasing healing speed of human and animal wounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US37901A (en) * | 1863-03-17 | Improved liniment | ||
| US55911A (en) * | 1866-06-26 | Improved medical compound | ||
| US202246A (en) * | 1878-04-09 | Improvement in medical compounds | ||
| US256847A (en) * | 1882-04-25 | Salve | ||
| DE819127C (de) * | 1949-09-28 | 1951-10-29 | Heinz Dr Bauer | Verfahren zur Herstellung eines Heilbades gegen Hautekzeme |
| DE812341C (de) * | 1950-03-07 | 1951-08-27 | Penicillin Ges Dauelsberg & Co | Verfahren zur Herstellung eines Hautbehandlungsmittels |
| DE833840C (de) * | 1950-06-01 | 1952-03-13 | Dr Heinz Bauer | Verfahren zur Herstellung einer Salbe gegen Hautekzeme |
| US3928584A (en) * | 1969-06-30 | 1975-12-23 | Us Health Education & Welfare | Extracts from active tree saps for treating P388 mouse leukemia |
| US4059695A (en) * | 1974-02-14 | 1977-11-22 | Kanari Hirosaki | Method for manufacturing a tonic composition for man and other animals |
| JPS60164467A (ja) * | 1984-02-07 | 1985-08-27 | Rooman Kogyo:Kk | 飲料 |
| EP0217975B1 (de) * | 1985-10-08 | 1991-12-04 | Psori-Med Ag | Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten |
| US4847083A (en) * | 1986-04-02 | 1989-07-11 | Dermasciences, Inc. | Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith |
| BE1000950A3 (fr) * | 1987-10-05 | 1989-05-23 | Claude Patricia | Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence. |
| AT393221B (de) * | 1988-02-03 | 1991-09-10 | Leopold Pharma Gmbh | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken |
| US5080900A (en) * | 1990-04-17 | 1992-01-14 | Stanley R Thomas | Treatment of skin ulcers with an aqueous extract of oak bark ash |
-
1993
- 1993-11-04 DK DK94900557T patent/DK0668769T3/da active
- 1993-11-04 HU HU9501323A patent/HUT73791A/hu active IP Right Revival
- 1993-11-04 CA CA002148795A patent/CA2148795C/en not_active Expired - Fee Related
- 1993-11-04 PL PL93308770A patent/PL308770A1/xx unknown
- 1993-11-04 PT PT94900557T patent/PT668769E/pt unknown
- 1993-11-04 CZ CZ951173A patent/CZ117395A3/cs unknown
- 1993-11-04 EP EP94900557A patent/EP0668769B1/en not_active Expired - Lifetime
- 1993-11-04 DE DE69328438T patent/DE69328438T2/de not_active Expired - Lifetime
- 1993-11-04 NZ NZ258019A patent/NZ258019A/xx not_active IP Right Cessation
- 1993-11-04 JP JP51222794A patent/JP3640215B2/ja not_active Expired - Fee Related
- 1993-11-04 BR BR9307401A patent/BR9307401A/pt not_active Application Discontinuation
- 1993-11-04 AT AT94900557T patent/ATE191850T1/de not_active IP Right Cessation
- 1993-11-04 AU AU55500/94A patent/AU700019B2/en not_active Ceased
- 1993-11-04 ES ES94900557T patent/ES2147780T3/es not_active Expired - Lifetime
- 1993-11-04 WO PCT/US1993/010670 patent/WO1994011010A2/en not_active Ceased
- 1993-11-05 ZA ZA938274A patent/ZA938274B/xx unknown
- 1993-11-08 MX MX9306960A patent/MX9306960A/es not_active IP Right Cessation
-
1995
- 1995-05-04 NO NO951740A patent/NO951740L/no unknown
- 1995-05-05 OA OA60657A patent/OA10153A/en unknown
-
1997
- 1997-10-08 US US08/947,055 patent/US6149947A/en not_active Expired - Fee Related
-
2001
- 2001-08-31 CY CY0100022A patent/CY2231B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994011010A3 (en) | 1994-09-15 |
| DE69328438T2 (de) | 2001-01-04 |
| US6149947A (en) | 2000-11-21 |
| HU9501323D0 (en) | 1996-05-28 |
| OA10153A (en) | 1996-12-18 |
| JP3640215B2 (ja) | 2005-04-20 |
| PL308770A1 (en) | 1995-08-21 |
| ATE191850T1 (de) | 2000-05-15 |
| CA2148795C (en) | 2004-08-10 |
| EP0668769A1 (en) | 1995-08-30 |
| DE69328438D1 (de) | 2000-05-25 |
| NO951740D0 (no) | 1995-05-04 |
| CY2231B1 (en) | 2003-04-18 |
| NZ258019A (en) | 1998-12-23 |
| CA2148795A1 (en) | 1994-05-26 |
| NO951740L (no) | 1995-06-19 |
| BR9307401A (pt) | 1999-08-24 |
| DK0668769T3 (da) | 2000-10-02 |
| ZA938274B (en) | 1994-06-09 |
| WO1994011010A2 (en) | 1994-05-26 |
| AU5550094A (en) | 1994-06-08 |
| HUT73791A (en) | 1996-09-30 |
| AU700019B2 (en) | 1998-12-17 |
| EP0668769B1 (en) | 2000-04-19 |
| PT668769E (pt) | 2000-10-31 |
| MX9306960A (es) | 1995-01-31 |
| JPH08503462A (ja) | 1996-04-16 |
| CZ117395A3 (en) | 1995-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9306960A (es) | Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion. | |
| WO1994011010B1 (en) | Compositions of oak bark extract, related synthetic compositions, and method of using same | |
| MX9200675A (es) | Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral. | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| ES2074867T3 (es) | Derivados de quinazolina para potenciar la actividad antitumoral. | |
| DE10199020I2 (de) | Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit. | |
| FI943805A0 (fi) | Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon | |
| FI972580A0 (fi) | Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi | |
| ES2033434T3 (es) | Composicion cosmetica. | |
| ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| RU94042393A (ru) | Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих | |
| IL64956A0 (en) | Tetrahydronaphthalene and indane derivatives,their manufacture and pharmaceutical compositions containing them | |
| ES2061811T3 (es) | Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera. | |
| ES2068714T3 (es) | Derivados de pirimidina para aumentar la actividad antitumoral. | |
| ES2074508T3 (es) | Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos. | |
| ATE93846T1 (de) | S-substituierte beta-thioacrylamide und deren verwendung als mikrobizide. | |
| NZ335057A (en) | Pentaerythritol derivatives, their production and use and intermediates for their synthesis | |
| DE69232852D1 (de) | Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen | |
| AU543542B2 (en) | Polymer compositions for treating tumours | |
| NZ220495A (en) | A2a cyclopeptan-2-ones carrier containing methotrexate compositions | |
| DE59303033D1 (de) | Hautbräunungsmittel | |
| DE3485282D1 (de) | Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren. | |
| ATE128354T1 (de) | Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen. | |
| GB8428552D0 (en) | Organic compounds | |
| ES2106858T3 (es) | Nuevos derivados de la citarabina, su procedimiento de preparacion y su uso contra enfermedades cancerosas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 668769 Country of ref document: ES |